The growth in the organ preservation solutions market is driven by several factors, including the rising incidence of chronic diseases such as diabetes, hypertension, and heart disease, which lead to organ failure and the subsequent need for transplants. The growing aging population also contributes to the increased demand for organ transplants, as older individuals are more likely to suffer from conditions that necessitate organ replacement. Furthermore, the number of organ transplant procedures is increasing globally, driven by advancements in surgical techniques and improved post-transplant care. Technological advancements in preservation methods, such as hypothermic and normothermic perfusion, are significantly enhancing organ viability and driving market demand. Hypothermic perfusion involves cooling the organ and continuously perfusing it with a cold preservation solution, while normothermic perfusion maintains the organ at normal body temperature and provides oxygenated blood or preservation solution. These methods have shown improved outcomes in terms of organ viability and function post-transplant. Additionally, the expanding healthcare infrastructure in emerging economies and increased government initiatives to support organ donation and transplantation are contributing to market growth. For example, many countries are implementing policies and programs to encourage organ donation and improve the management of donor organs. Improvements in donor organ management practices, such as better matching of donors and recipients and more efficient logistics for organ transportation, are further enhancing the success rates of transplants. Moreover, the development of innovative preservation solutions with better efficacy and longer preservation times is expected to sustain market growth in the coming years. The combined effect of these factors is propelling the organ preservation solutions market toward a promising future, characterized by improved transplant outcomes and increased availability of viable organs for transplantation.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Static Cold Storage Technique segment, which is expected to reach US$161.8 Million by 2030 with a CAGR of a 5.1%. The Hypothermic Machine Perfusion Technique segment is also set to grow at 6.0% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $68.4 Million in 2023, and China, forecasted to grow at an impressive 4.7% CAGR to reach $57.1 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Organ Preservation Solutions Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Organ Preservation Solutions Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Organ Preservation Solutions Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as 21st Century Medicine, BioLife Solutions, Inc., Dr. Franz Köhler Chemie GmbH, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 13 Featured):
- 21st Century Medicine
- BioLife Solutions, Inc.
- Dr. Franz Köhler Chemie GmbH
- Essential Pharmaceuticals, LLC
- Lifeline Scientific, Inc.
- Preservation Solutions, Inc.
- XVIVO Perfusion AB
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 21st Century Medicine
- BioLife Solutions, Inc.
- Dr. Franz Köhler Chemie GmbH
- Essential Pharmaceuticals, LLC
- Lifeline Scientific, Inc.
- Preservation Solutions, Inc.
- XVIVO Perfusion AB
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 179 |
Published | November 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 257.4 Million |
Forecasted Market Value ( USD | $ 361.5 Million |
Compound Annual Growth Rate | 5.0% |
Regions Covered | Global |